Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016
- PMID: 30182795
- DOI: 10.1177/0269881118793086
Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016
Abstract
Background: Lysergic acid diethylamide (LSD) and psilocybin are serotonergic hallucinogens that are used primarily for recreational abuse. Small studies evaluated the efficacy of LSD and psilocybin for several psychiatric conditions. There are limited safety or toxicity data for either of these substances, especially in large populations.
Methods: This was a retrospective analysis of single-substance exposures of LSD or psilocybin-containing mushrooms (PcMs) reported to United States poison centers from 1 January 2000 to 31 December 2016. The study describes the most frequent toxicities, management sites, and medical outcomes.
Results: A total of 5883 PcM and 3554 LSD exposures were included. Most patients were between 13 and 29 years of age (83.9% PcM, 88.9% LSD) and primarily male (77.9% PcM, 74.1% LSD). Most common clinical effects were hallucinations (45.8% PcM, 37.4% LSD), agitation (24.1% PcM, 42.4% LSD), and tachycardia (18.0% PcM, 38.6% LSD). Serious clinical effects were infrequent, but included hyperthermia, seizures, coma, increased serum creatinine, and cardiac arrest. Most patients were treated and released from the emergency department. More LSD patients were admitted to critical care and non-critical care units than PcM patients. Moderate effect was the most frequent outcome for both substances (61.0% PcM, 62.3% LSD).
Conclusion: These data find that LSD and PcM use occurs primarily in adolescents and young adults, who experience mild to moderate adverse effects. Serious effects are infrequent but can occur. While most LSD and PcM users require only emergency department management, LSD use is more likely to require medical admission.
Keywords: Lysergic acid diethylamide (LSD); drug abuse; poison center; psilocybin.
Similar articles
-
The psychedelic call: analysis of Australian Poisons Information Centre calls associated with classic psychedelics.Clin Toxicol (Phila). 2024 Apr;62(4):242-247. doi: 10.1080/15563650.2024.2346612. Epub 2024 May 16. Clin Toxicol (Phila). 2024. PMID: 38753585
-
A cluster of lysergic acid diethylamide (LSD) poisonings following insufflation of a white powder sold as cocaine.Clin Toxicol (Phila). 2021 Nov;59(11):969-974. doi: 10.1080/15563650.2021.1904140. Epub 2021 Apr 13. Clin Toxicol (Phila). 2021. PMID: 33849370
-
Analysis of mushroom exposures in Texas requiring hospitalization, 2005-2006.J Med Toxicol. 2009 Jun;5(2):59-62. doi: 10.1007/BF03161087. J Med Toxicol. 2009. PMID: 19415588 Free PMC article.
-
[Hallucinogenic mushrooms].Medicina (Kaunas). 2005;41(12):1067-70. Medicina (Kaunas). 2005. PMID: 16401965 Review. Lithuanian.
-
Addressing the Current Knowledge and Gaps in Research Surrounding Lysergic Acid Diethylamide (LSD), Psilocybin, and Psilocin in Rodent Models.Curr Top Med Chem. 2023;23(23):2232-2241. doi: 10.2174/1568026623666230705151922. Curr Top Med Chem. 2023. PMID: 37409550 Review.
Cited by
-
Content analysis of Reddit posts about coadministration of selective serotonin reuptake inhibitors and psilocybin mushrooms.Psychopharmacology (Berl). 2024 Apr 30. doi: 10.1007/s00213-024-06585-x. Online ahead of print. Psychopharmacology (Berl). 2024. PMID: 38687360
-
Structure-activity relationships of serotonergic 5-MeO-DMT derivatives: insights into psychoactive and thermoregulatory properties.Mol Psychiatry. 2024 Mar 14. doi: 10.1038/s41380-024-02506-8. Online ahead of print. Mol Psychiatry. 2024. PMID: 38486047
-
5-MeO-DMT: An atypical psychedelic with unique pharmacology, phenomenology & risk?Psychopharmacology (Berl). 2023 Dec 11. doi: 10.1007/s00213-023-06517-1. Online ahead of print. Psychopharmacology (Berl). 2023. PMID: 38072874 Review.
-
Case report: Psychedelic-induced seizures captured by intracranial electrocorticography.Front Neurol. 2023 Jun 29;14:1214969. doi: 10.3389/fneur.2023.1214969. eCollection 2023. Front Neurol. 2023. PMID: 37456653 Free PMC article.
-
Lysergic acid diethylamide stimulates cardiac human H2 histamine and cardiac human 5-HT4-serotonin receptors.Naunyn Schmiedebergs Arch Pharmacol. 2024 Jan;397(1):221-236. doi: 10.1007/s00210-023-02591-6. Epub 2023 Jul 4. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 37401967 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources